Patents Assigned to MYOFORTE THERAPEUTICS, INC.
  • PGDH inhibitors and methods of making and using
    Patent number: 11891389
    Abstract: Disclosed herein are compounds that can inhibit 15-hydroxyprostaglandin dehydrogenase. Such compounds may be administered to subjects that may benefit from modulation of prostaglandin levels.
    Type: Grant
    Filed: April 20, 2022
    Date of Patent: February 6, 2024
    Assignee: Myoforte Therapeutics, Inc.
    Inventors: Roopa Rai, Robert Booth, Michael J. Green
  • PGDH inhibitors and methods of making and using
    Patent number: 11345702
    Abstract: Disclosed herein are compounds that can inhibit 15-hydroxyprostaglandin dehydrogenase. Such compounds may be administered to subjects that may benefit from modulation of prostaglandin levels.
    Type: Grant
    Filed: September 24, 2021
    Date of Patent: May 31, 2022
    Assignee: MYOFORTE THERAPEUTICS, INC.
    Inventors: Roopa Rai, Robert Booth, Michael J. Green